Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic
Condition: TuberculosisInterventions: Drug: etoricoxib; Biological: H56:IC31Sponsors: Anne Margarita Dyrhol Riise; University of Oslo; Statens Serum InstitutNot yet recruiting - verified July 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials